Ubenimex Completed Phase 3 Trials for Stroke, Ischemic Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science3
clinicaltrials.gov IdentifierTitleDrugs
NCT03402204Efficacy of High and Low-Dose Simvastatin on Vascular Oxidative Stress and Neurological Outcome in Patients With AIS